NASDAQ: ELUT
Elutia Inc Earnings Dates, Reports, Calls

Elutia earnings were -$26.5M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest ELUT earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$3.9M, down 59.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ELUT reported annual earnings of -$53.9M, with 43.3% growth.

ELUT earnings history

Current Revenue
$21.1M
Current Earnings
-$26.5M
Current Profit Margin
-125.6%

ELUT Return on Equity

Current Company
N/A
Current Industry
13.3%
Current Market
35.2%

ELUT undefined

Current Company
-76.4%
Current Industry
7.8%
ELUT is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ELUT announces earnings.

ELUT undefined

Current Company
197.1%
Current Industry
8.5%
ELUT has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ELUT vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ELUT-$20.16M-$26.47MN/A-$0.63
NMTC-$4.97M-$5.34MN/A-$0.15
IINN-$10.71M-$11.21MN/A-$0.46
HIND-$11.27M-$11.35MN/A-$125.12
COCH-$19.54M-$28.61MN/A-$1.42

Elutia Earnings Reports & History FAQ

What were Elutia's earnings last quarter?

On ELUT's earnings call on Invalid Date, Elutia (NASDAQ: ELUT) reported Q3 2025 earnings per share (EPS) of -$0.09, up 400% year over year. Total ELUT earnings for the quarter were -$3.87 million. In the same quarter last year, Elutia's earnings per share (EPS) was $0.03.

If you're new to stock investing, here's how to buy Elutia stock.

Is Elutia profitable or losing money?

As of the last Elutia earnings report, Elutia is currently losing money. Elutia's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$26.47 million, a 51.16% decrease year over year.

What was ELUT's earnings growth in the past year?

As of Elutia's earnings date in Invalid Date, Elutia's earnings has grown year over year. ELUT earnings in the past year totalled -$26.47 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.